| Literature DB >> 34202116 |
Claudia Foerster1, Gisela Ríos-Gajardo2, Patricia Gómez2, Katherine Muñoz3, Sandra Cortés4,5, Carlos Maldonado1, Catterina Ferreccio5.
Abstract
Aflatoxin B1 (AFB1), ochratoxin A (OTA), zearalenone (ZEN), and deoxynivalenol (DON) are frequent mycotoxins that may cause carcinogenic, mutagenic, estrogenic, or gastrointestinal effects. The aim of this study was to assess the exposure to and risk from AFB1, OTA, ZEN, and DON in 172 participants of the Maule Cohort (MAUCO) by a biomarker analysis in urine and to associate their exposure with food consumption and occupation. Mycotoxins in the first morning urine were analyzed by solid-phase extraction and quantified by Ultra-High-Performance Liquid Chromatography with a mass-mass detector. Participants' information regarding food consumption, occupation, and other characteristics was obtained from a baseline and 2-year follow-up survey of the cohort. The prevalence and mean levels of mycotoxins in the urine were as follows: DON 63%, 60.7 (±78.7) ng/mL; AFB1 8%, 0.3 (±0.3) ng/mL; α-zearalenol (α-ZEL) 4.1%, 41.8 (±115) ng/mL; β-ZEL 3.5%, 17.4 (±16.1) ng/mL; AFM1 2%, 1.8 (±1.0) ng/mL; OTA 0.6% (1/172), 1.3 ng/mL; and ZEN 0.6%, 1.1 ng/mL. These results were translated into exposures of DON, ZEN, and aflatoxins of public health concern. Participants who consumed coffee and pepper the day before had a significantly greater presence of DON (OR: 2.3, CI95 1.17-4.96) and total ZEL (OR: 14.7, CI95 3.1-81.0), respectively, in their urine. Additionally, we observed associations between the habitual consumption of beer and DON (OR: 2.89, CI95 1.39-6.42). Regarding the levels of mycotoxins and the amount of food consumed, we found correlations between DON and nuts (p = 0.003), total ZEL and cereals (p = 0.01), and aflatoxins with capsicum powder (p = 0.03) and walnuts (p = 0.03). Occupation did not show an association with the presence of mycotoxins in urine.Entities:
Keywords: Chile; aflatoxin; deoxynivalenol; food; occupation; ochratoxin A; urine biomonitoring; zearalenone
Mesh:
Substances:
Year: 2021 PMID: 34202116 PMCID: PMC8309762 DOI: 10.3390/toxins13070439
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Sociodemographic characteristics of participants of the study (n = 172), stratified by sex.
| Characteristics | All | Women | Men | |
|---|---|---|---|---|
|
| 57.4 ± 9.3 | 58.5 ± 8.8 | 56.4 ± 9.7 | 0.129 a |
| 35–44 | 10.5 | 6.2 | 14.3 | |
| 45–54 | 26.7 | 27.2 | 26.4 | |
| 55–64 | 39.0 | 40.7 | 37.4 | |
| 65–74 | 23.8 | 25.9 | 22.0 | |
|
| 29.3 ± 4.5 | 29.5 ± 5.3 | 29.1 ± 3.8 | 0.536 a |
|
| 0.222 b | |||
| Chilean/Hispanic | 98.8 | 97.5 | 100 | |
| Mapuche | 1.2 | 2.5 | 0 | |
|
| 0.177 b | |||
| ≤8 | 55.8 | 61.7 | 50.5 | |
| 9–12 | 34.3 | 27.2 | 40.7 | |
| ≥13 | 9.9 | 11.1 | 8.8 | |
|
| 43.9 | 51.1 | 37.7 | 0.269 b |
|
| 66.7 | 60.5 | 72.2 | 0.143 b |
|
| 22.5 | 17.3 | 27.1 | 0.183 b |
|
| 48.2 | 34.2 | 60.0 |
|
|
| 11.4 | 7.8 | 14.4 | 0.226 b |
ap-values obtained from t-tests (continuous variable); bp-values obtained from Chi-square tests (categorical variables).
Daily food consumption (g or mL/day) for the participants of the study (n = 172), stratified by sex.
| Consumption | Food Item | All (Mean ± SD) | Women (Mean ± SD) | Man (Mean ± SD) | |
|---|---|---|---|---|---|
|
| Capsicum | 0.8 ± 2.0 | 0.7 ± 1.9 | 1.0 ± 2.0 | 0.230 |
| Cereal (whole) | 6.0 ± 13.1 | 8.2 ± 16.6 | 4.1 ± 8.5 | 0.540 | |
| Beer | 62.6 ± 268.2 | 45.6 ± 350 | 77.8 ± 165.2 | 0.002 | |
| Maize | 149.2 ± 166.5 | 125 ± 84.7 | 165.7 ± 204.3 | 0.898 | |
| Nuts | 9.8 ± 9.5 | 10 ± 9.9 | 9.5 ± 9.1 | 0.988 | |
| Dairy | 110.6 ± 95.8 | 117.4 ± 96.8 | 104.5 ± 95.1 | 0.338 | |
| Legumes | 53.4 ± 31.9 | 50.1 ± 28.8 | 56.4 ± 34.4 | 0.274 | |
| Wine | 134.9 ± 421.1 | 89.1 ± 309.7 | 175.6 ± 498.1 | 0.103 | |
|
| Capsicum | 0.7 ± 1.9 | 0.8 ± 2.1 | 0.7 ± 1.6 | 0.863 |
| Coffee | 1.9 ± 3.7 | 1.6 ± 2.9 | 2.2 ± 4.3 | 0.408 | |
| Meat | 60.4 ± 56.8 | 57.5 ± 55.9 | 63 ± 57.8 | 0.448 | |
| Cereal | 3.5 ± 10 | 3.9 ± 10.5 | 3.1 ± 9.5 | 0.607 | |
| Maize | 4.8 ± 19.7 | 5.2 ± 20.4 | 4.4 ± 19.2 | 0.623 | |
| Ginger | 0.2 ± 1.1 | 0.4 ± 1.4 | 0.1 ± 0.5 | 0.019 | |
| Legumes | 45.3 ± 99.9 | 44.6 ± 91.5 | 45.9 ± 107.3 | 0.767 | |
| Peanut | 3.0 ± 9.0 | 3.0 ± 9.0 | 3.0 ± 9.0 | 0.998 | |
| Walnut | 1.3 ± 5.9 | 1.3 ± 4.9 | 1.2 ± 6.7 | 0.595 | |
| Tea | 7.6 ± 6.5 | 8.1 ± 7.4 | 7.0 ± 5.5 | 0.551 |
SD: Standard deviation.
Prevalence and concentrations of detected mycotoxins found in the urine of the 172 participants of this study, along with the limit of detection (LOD) and quantification (LOQ) of the method.
| Mycotoxin | LOD | LOQ | Over | Prevalence | Mean (SD) | Mean (SD) | Median (IQ Range) |
|---|---|---|---|---|---|---|---|
| AFB1 | 0.08 | 0.1 | 7 | 8 | 0.3 (0.3) | 0.3 (0.2) | 0.3 (0.1–0.3) |
| AFM1 | 0.8 | 1.1 | 1 | 1 | 1.8 (1.0) | 4.3 (2.8) | 1.8 (1.5–2.2) |
| OTA | 0.4 | 2.1 | 0 | 0.6 | - | - | - |
| DON | 6.6 | 20.1 | 63 | 73 | 60.7 (78.7) | 64.6 (205.8) | 37.6 (23.2–61.1) |
| ZEN | 0.5 | 1.7 | 0 | 0.6 | - | - | - |
| α-ZEL | 1.2 | 3.7 | 6 | 8 | 41.8 (115.5) | 19.1 (25.2) | 11.8 (6.2–16.5) |
| β-ZEL | 0.7 | 2.3 | 7.5 | 7.5 | 17.4 (16.1) | 21.9 (57.8) | 8.6 (6.9–31.3) |
a ng/mg creatinine-adjusted; IQ range: interquantile range; SD: standard deviation.
Figure 1Hazard Quotient (HQ) of prevalent participants for deoxynivalenol (DON) in urine (n = 125). The red line shows an HQ of 1. If the HQ > 1, the exposure could be of health concern. An HQ > 5 (outliers) was not considered in the figure (n = 6).
Comparative prevalence (%) and mean levels (ng/L) of aflatoxins, ochratoxin A (OTA), deoxynivalenol (DON), and zearalenone (ZEN), as well as their metabolites α-zearalenol (α-ZEL) and β-zearalenol (β-ZEL) analyzed in adults’ urine of different countries.
| Mycotoxin | Chile (This study) | Belgium [ | Italy [ | Germany [ | Germany [ | Sweden [ | Brazil [ | Haiti [ | USA [ | South Africa [ | |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
| 9 | - | 6 | 0 | - | - | 12 | 11 | 13 | 0 |
|
| 0.6 | 35 | 100 | 15 | 77 | 51 | 27 | 47 | 87 | 96 | |
|
| 55 | 37 | 96 | 8 | 100 | 63 | 88 | 24 | - | 87 | |
|
| 0.6 | - | 100 | - | 100 | 37 | 7 | - | - | 100 | |
|
| 8 | 0.4 | 100 | 0 | 46 | 21 | 0 | 4 | - | 92 | |
|
| 6 | - | 98 | - | 23 | 18 | 0 | - | - | 75 | |
|
|
| 500 | - | 68 | - | - | - | 20 * | 60 | 4670 | - |
|
| - | 27.8 | 140 | 97 | 66 | 460 | 20 * | 110 | 6200 | 24 | |
|
| 60,700 | 3900 | 11,890 | 2000 | 6850 | 3370 | 12,000 * | 3200 | - | 4940 | |
|
| 1100 | - | 60 | - | 31 | 30 | 20 * | - | - | 204 | |
|
| 41,800 | 5000 | 80 | - | 16 | 30 | - | 1460 | - | 247 | |
|
| 17400 | - | 90 | 1420 | 8 | 20 | - | - | - | 244 |
* Creatinine-adjusted.